Author

A Bedi

Observed name: A. Bedi

Institutions: Johns Hopkins University, Johns Hopkins Medicine

Observed institutions: Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital

ORCID: 0009-0001-4479-1022

Observed ORCID: 0009-0001-4479-1022

OpenAlex ID: A5000689059

Inhibition of apoptosis during development of colorectal cancer.

1995 · A Bedi, P J Pasricha, et al. · PubMed · 541

Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia

1994 · A Bedi, BA Zehnbauer, et al. · Blood · 508

BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents

1995 · A Bedi, JP Barber, et al. · Blood · 348

Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors

2017 · E. Izumchenko, K. Paz, et al. · Annals of Oncology · 336

Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation.

1995 · A Bedi, C B Miller, et al. · Journal of Clinical Oncology · 314

p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300.

1998 · R Ravi, B Mookerjee, et al. · PubMed · 156

Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest.

2001 · G Niu, K H Shain, et al. · PubMed · 127

BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia

1993 · A Bedi, BA Zehnbauer, et al. · Blood · 121

CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB.

1998 · R Ravi, A Bedi, et al. · PubMed · 120

Patient‐derived xenografts as tools in pharmaceutical development

2016 · E Izumchenko, J Meir, et al. · Clinical Pharmacology & Therapeutics · 57

Requirement of p34cdc2 kinase for apoptosis mediated by the Fas/APO-1 receptor and interleukin 1beta-converting enzyme-related proteases.

1996 · S L Yao, K A McKenna, et al. · PubMed · 56

Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis.

1995 · E J Fuchs, A Bedi, et al. · PubMed · 46

Are growth factors leukemogenic?

1996 · R A Brodsky, A Bedi, et al. · PubMed · 22

Biological significance and molecular mechanisms of p53-induced apoptosis

1998 · A. Bedi, B. Mookerjee · APOPTOSIS · 16

Inhibition of apoptosis in familial adenomatous polyposis (FAP) and its modification by sulindac

1995 · P.J. Pasricha, A. Bedi, et al. · Gastroenterology · 2

Quality of Responses Generated by Artificial Intelligence Chatbots for Frequently Asked Questions by Caregivers of Presurgical Nasoalveolar Molding Therapy

2026 · Madhanraj Selvaraj, J Monisha, et al. · The Cleft Palate-Craniofacial Journal

Works count: 16

Citation count: 2,887

H-index: 15

I10-index: 15